ArticleProceedings of the National Academy of Sciences of the United States of America2022

A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets.

Xiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.